Articles

*** Three Events: Tuesday, Oct. 27, 2020 at 11am EDT| 8am PDT| 3pm GMT| 4pm CET Asia Pacific: Wednesday, Oct. 28, 2020 at 10:30 am IST| 1pm CST| 2pm JST Europe: Wednesday, Oct. 28, 2020 at 9am| 10am CET*** Characterizing complex nanoparticles, polymers and biotherapeutics is about to get a lot easier. ***On demand available after final airing until Oct. 28, 2021***

Breakthroughs in FFF-MALS – New Levels of Performance and Usability

***Live: Thursday, Oct. 22, 2020 at 10am EDT| 9am CDT| 3pm BST| 4pm CEST***Process development for anchorage-dependent cells at bench scale is crucial to establish cost-efficient workflows in larger volumes. Learn how different process parameter can be monitored and controlled in a perfusion bioprocess and the potential of using packed-bed bioreactors or a microcarrier spin filter for attachment cell-based vaccine production.. *** On demand available after final airing until Oct. 22, 2021.***

Vero Cell Cultivation for Vaccine Production 

***Live: Wednesday, Oct. 21, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST*** Host cell proteins (HCPs) can compromise a biologic drug and delay its development program. Learn about important considerations for optimizing HCP testing in this webcast. ***On demand available after final airing until Oct. 21, 2021***

Host Cell Proteins: Analytical and Regulatory Challenges

***Live: Monday, Oct. 19, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST*** Learn about the challenges of N-nitrosamines analysis and mass spectrometry and complimentary orthogonal mass spectrometry techniques can be used to address these challenges.. *** On demand available after final airing until Oct. 19, 2021.***

Overcome N-Nitrosamine Analysis Challenges with Chromatographic and Mass Spectrometry Techniques 

***Live: Wednesday, Oct. 14, 2020, at 11am EDT| 8am PDT| 4pm BST| 5pm CEST*** Hear experts review key milestones and tasks—as well as potential stumbling blocks—along the drug development pathway and offer strategies to help discovery-phase drug development programs move from the lab to clinic and commercialization. *** On demand available after final airing until Oct. 14, 2021.***

Editors’ Series: Mapping the Transition from Drug Discovery to Development and Beyond

***Live: Tuesday, Oct. 13, 2020 at 12pm EDT| 9am PDT| 5pm BST*** Single cell analysis methods have transformed our ability to understand biology and disease. Pharmaceutical and biotech companies are now using single cell methods to accelerate their drug discovery efforts. Learn how to get started with single cell analysis using an optimized automation platform. *** On demand available after final airing until Oct. 13, 2021.***

Automated single cell workflow for drug discovery and development

Non-infectious mock virus particles that mimic the physicochemical properties of live infectious
viruses can be used as spiking agents during viral clearance testing. Review results from several studies using an economical spiking surrogate—a non-infectious minute virus of mice-mock virus particle (MVM-MVP)—to demonstrate viral clearance in industrial processes. 

Tuesday, Oct 6, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
On demand available after final airing until Oct. 6, 2021.

Predicting Viral Clearance: DOE, HTS, and AAV Case Studies Using a Non-Infectious MVM Surrogate in Downstream Development

The cold chain distribution of biopharmaceutical products is hampered by product loss from brittle components and temperature excursions. Learn about a risk-mitigation strategy and study results that highlight the importance of choosing the right low-temperature materials, use sensors for monitoring the distribution process step, and testing to qualify a single-use cold chain solution.  

Monday, Oct. 12, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
On demand available after final airing until Oct. 12, 2021.

Risk Mitigation for Single-Use Cold Chain Distribution

Media fill tests ensure the safe production of parenteral drugs. Learn factors to consider when selecting media for aseptic process simulations including US and European regulatory requirements and eser requirement specifications for equipment and instruments.

Tuesday Sept. 29, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after final airing until Sept. 29, 2021.



Media Selection Made Easy:  Selecting the Best Media for Your Aseptic Process Simulation

Biopharmaceutical companies are transitioning from “quality-by-testing” philosophy to “quality-by-design” paradigms, and establishing QbD-based PAT tools to increase product and process understanding. Due to the deficit of analytical methods to support QbD-driven continuous bioprocessing, biopharmaceutical companies are actively developing PAT tools to comply with QbD regulations.

Europe Broadcast: Wednesday, Sept. 30, 2020 at 9am EDT | 2pm BST | 3pm CEST

US Broadcast: Wednesday, Sept. 30, 2020 at 2pm EDT | 1pm CDT | 11am PDT
On demand available after final airing until Sept. 30, 2021.

Process Analytical Technology (PAT): Online Monitoring and Control of Upstream Titer, Product Quality and Amino Acid Content Using 2D-LC with SegFlow Interface

Webcasts